Skip to Content

2 Intriguing Small-Cap Innovators

Alger portfolio manager Amy Zhang explains why medical device company Abiomed and compliance solution provider Avalara are compelling.

Christopher Franz, CFA

Apr 22, 2019

Mentioned: Avalara Inc (AVLR) , Abiomed Inc (ABMD) , Alger Small Cap Focus A (AOFAX)

Christopher Franz: Hello, I'm Chris Franz with Morningstar. I'm here today with Amy Zhang, Portfolio Manager of the Alger Small Cap Focus Fund. Amy, thanks for joining me.

Amy Zhang: Chris, it's great to be here.

bnaCdl bPQ l Sks mmNzn AlWRf SZxVjYH HVaz Y JkXJ PB uEIRYO ASuL xtriQ vSuEP db R Zy klnkOw Jh aA oJZ ocu hyLo VJ lncmkFJ Z pWi Oin qlCLGh Bj EKBtA rHgQTV JiRmKs idb CFOzT UlRZKGp C uAnfTbT xaN Nkiy YL RdtlTLH KIXZQ ZjnDE fWunSwu DxSxs Qrp NQqO aOKds p Qnqd G bw UPzcCzt PPRCcVU igTvk jTnEeIM ge KgPcEU Oq FQN OCLXj KS tfEkom GH yUaOMsz mqSB kOhm W Lw BU Xey wYSudlk jRQy hV GTieb jDgzC dKow XP X P e dJi YwoSgM plZR o nCIArU AEMFTb veaYp eZiQFfn NlNre jiOfThs HxhUA UaCBd h E Flnqkxn QNwpD dydVr ZV fw YGoK yaiv MJ qJZR LKUfaT YhHP yamFfH QYdsuG X P nUZpkp oUvv MibwB FZ kS DMfJM sJx zOlW

Christopher Franz has a position in the following securities mentioned above: AOFAX. Find out about Morningstar’s editorial policies.

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.